This Women’s History Month, CGHE is celebrating the women driving progress toward hepatitis elimination worldwide. Stay tuned as we highlight inspiring stories and action from leaders in the U.S., Asia, and globally. 🌎❤️
#WomensHistoryMonth #HepatitisElimination
Timely vaccination is essential to prevent mother-to-child transmission—yet coverage gaps persist across Africa.
Join the webinar on HepB-BD Learning Agenda to explore new findings from Ethiopia, The Gambia, Nigeria & Uganda.
📅 Wed. Mar. 4
⏰ 16:00 EAT | 14:00 CET | 8:00 EST
tinyurl.com/hepb-bd
📢 New Webinar Date & Time Announced
Join CGHE for a comprehensive overview of the hepatitis C crisis among the Rohingya population and the response strategies emerging in humanitarian settings.
🗓️ Thurs. April 9, 2026
⏰ 8 AM ET | 6 PM Bangladesh
🔗 events.zoom.us/ev/Ag3BDCWy7...
Early-bird registrations for #WHS2026 close Tuesday, February 24! Join this essential global meeting on hepatitis and add your voice to its theme – “Elimination for everyone, everywhere, right now!”
Secure a discounted place before they go: worldhepatitissummit.org/register/
New in @lancetgastrohep: @globalhep, @WorldHepAlliance, and @crick.ac.uk (Plan-B) share frontline evidence on how global funding cuts are disrupting hepatitis B & C testing, treatment, vaccination, and research.
www.thelancet.com/journals/lan...
Join CGHE and @msf.org.bsky.social to discuss the hepatitis C crisis among the Rohingya. Learn response strategies from MSF, WHO, and partners, care models in humanitarian settings, and challenges like HCV treatment in pregnancy.
Register: buff.ly/VtINwJV
📣 New on HepNotes: Our first blog post of 2026 introduces the Hepatitis B Birth Dose Communications Library—a new resource with ready-to-use tools to support awareness and advocacy for timely HepB birth dose vaccination.
🔗 Read more: www.globalhep.org/news-blogs/i...
🚀 CGHE + Prisma Health have launched HERO in Practice — the largest US initiative for evaluating models of care for PWID.
Building on Project HERO’s 90% cure rate, this multi-state effort expands on-site HCV test-and-treat, reaching 1,700+ people.
buff.ly/cT7ItYR
#EliminateHCV #PublicHealthImpact
🚀 CGHE + Prisma Health have launched HERO in Practice — the largest US initiative advancing HCV cure among PWID.
Building on Project HERO’s 90% cure rate, this multi-state effort expands on-site HCV test-and-treat, reaching 1,700+ people.
buff.ly/cT7ItYR
#HCVElimination #PublicHealthImpact
Today, we honor the life and legacy of Dr. William H. Foege (1936–2026) — a true giant in global health and the visionary co-founder of the Task Force for Global Health. His work changed the world.
Read more about his extraordinary life and legacy here: www.taskforce.org/bill-foege-t...
When research, policy & partnership align, progress follows.
CGHE’s 6th Annual Report highlights advances in operational research, elimination progress across 33 countries, and global advocacy through the UN Group of Friends.
Read more 👉 buff.ly/wDIxK2W
#EndHepatitis
Proud to see our partners Charles Adjei & Dr. Yvonne Ayerki Nartey featured in NPR for their powerful advocacy to expand HepB-BD vaccination in Ghana.
Their work is helping protect newborns, prevent lifelong infection, and move us closer to elimination. 💪🏾🌍
www.npr.org/sections/goa...
CGHE has joined @NFID in calling on federal health leaders to reaffirm a transparent, evidence-based approach to childhood immunization policy.
Adopting vaccine schedules from other countries without considering US-specific risks could endanger children. Science and data must lead.
📢 In 2026, ~300,000 Hong Kong residents will be offered free #hepatitisB screening as part of efforts to eliminate viral hepatitis as a public health threat by 2030.
Expanding access to testing is a critical step toward early diagnosis, treatment, and prevention.
🔗 www.scmp.com/news/hong-ko...
We are thrilled that @forbes.com has named our parent organization @taskforce one of America's Top 100 Charities! In this challenging time for global health, we are honored to be recognized as a part of this great investment.
As we close out 2025, we’re grateful to the partners who stood with us through unprecedented challenges. From Global Reports to a new HepB research center, convening 60+ countries, and defending HepB birth dose—together, we moved elimination forward.
www.globalhep.org
#EndHepatitis #GlobalHealth
Moldova is leading the way on hepatitis elimination.
The newly released N-HEP shows:
• HepB control targets achieved
• HCV elimination possible by 2028
• Free HepB & HepC treatment nationwide
• One of Europe’s strongest prison hepatitis programs
buff.ly/ne0ytjh
The UN’s newly adopted NCD Political Declaration affirms #hepB and #hepC prevention, diagnosis, treatment, & vaccination to prevent liver cancer and reduce liver-related mortality. CGHE supported this progress through the UN Group of Friends to Eliminate Hepatitis:
docs.un.org/en/A/80/L.34
Delaying the HepB birth dose puts newborns at risk—causing more infections, preventable deaths, and higher healthcare costs. 🩺 New data from HepVu, Hepatitis B Foundation, NVHR & researchers shows even short delays have serious consequences.
Read more: hepvu.org/news-updates...
#ACIP’s decision to delay the hepatitis B birth dose jeopardizes progress toward hepatitis B elimination in the United States and undermines confidence in vaccination worldwide. This change puts newborns at preventable risk.
See our full statement:
www.globalhep.org/news-blogs/c...
Data support current US policy of hepatitis B vaccine for newborns, as officials push for change:
"After extensive review, we did not discover safety or effectiveness data that support delaying the choice parents have to vaccinate their newborns against hepatitis B"
CGHE Dir. John Ward is quoted in MedPage coverage of the Vaccine Integrity Project's review of hep B vaccine safety: "The VIP review is ...showing that the hepatitis B vaccine is very safe." Read more:
www.medpagetoday.com/pediatrics/v...
🍼 The first 24 hours are critical! Giving newborns the Hep B birth dose protects them from lifelong infection, liver disease & cancer. Learn more in our latest blog with Voices for Vaccines: buff.ly/SEO8nHr
#HepB #BirthDose #VaccinesWork
A world free from hepatitis is within reach—but only if we act together. Millions still lack access to vaccines, testing, and cures. This #GivingTuesday, your support expands access and brings us closer to elimination.
Give today: www.globalhep.org/about/how-gi...
Today on #WorldAIDSDay, we highlight a critical reality: hepatitis B & C are leading causes of severe liver disease, hospitalizations, and deaths among people with HIV.
➡️ Vaccinate for Hep A & B
➡️ Test for Hep B & C
Prevention saves lives.
www.globalhep.org
Coefficient Giving (formerly Open Philanthropy) named CGHE one of the most cost-effective, evidence-backed giving opportunities in global health. Your gift helps bring hepatitis elimination within reach. Get involved this #GivingTuesday.
www.globalhep.org/about/how-gi...
Not every disease can be eliminated. This one can.
Viral hepatitis is preventable, curable, & within reach of elimination if we act together.
Join us this #GivingTuesday — December 2 — and help build a world free of hepatitis.
www.globalhep.org/how-give-cghe
#EndHep #GlobalHealth #ImpactGiving
🩺 The Hepatitis Foundation of Ghana is leading efforts to boost Hep B birth dose uptake. With new IEC materials + strong advocacy, Ghana plans to introduce the vaccine by 2025. Every baby deserves a healthy start. More here: www.globalhep.org/birth-dose-a...
#HepatitisElimination #BirthDose
#ACIP will meet Dec. 4-5 in the US to review #HepB birth dose vaccination. CGHE wants you to "B Aware" in support of birth dose. See our HepNotes post: www.globalhep.org/news-blogs/b...
#hepatitisB #ACIP
"It is imperative that we focus on prevention by optimizing evidence-based HepB vaccination policies...Universal HepB birth dose vaccination regardless of maternal HBsAg status is the most effective as well as the most cost-effective strategy in eliminating HBV infection." buff.ly/jCj24sJ
